MMEX is moving along, increasing its toxic debt load. MMEX excels at this task, piling on expensive (high cost of capital) toxic debt in $100K chunks, and billions of shares of dilution. Go MMEX!
MMEX is moving along, maximizing Class A common share-holder dilution, having inflated its total A/S to 12-billion shares (Twelve Billion Shares, yes, you read it right, straight from MMEX's filings). MMEX moved along on this task, with no independent, outside director guidance, or shareholder consent. Go MMEX!
MMEX is moving along, toward the April 8, 2018 OTCQB cure deadline, at which point the company will either delist from QB, or execute a reverse split, crushing shareholders virtually out of existence. Yep, MMEX is "moving right along" "with things." Go MMEX!